Published online
doi:10.1083/jcb.200610046
The Journal of Cell Biology, Vol. 176, No. 5, 709-718
The Rockefeller University Press, 0021-9525 $30.00
© Ge et al.
Critical role of the extracellular signalregulated kinaseMAPK pathway in osteoblast differentiation and skeletal development
Chunxi Ge1,2,
Guozhi Xiao4,
Di Jiang1,2, and
Renny T. Franceschi1,2,3
1 Department of Periodontics and Oral Medicine and 2 Center for Craniofacial Regeneration, University of Michigan School of Dentistry, Ann Arbor, MI 48109
3 Department of Biological Chemistry, University of Michigan School of Medicine, Ann Arbor, MI 48109
4 Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15240
Correspondence to Renny T. Franceschi: rennyf{at}umich.edu
The extracellular signalregulated kinase (ERK)mitogen-activated protein kinase (MAPK) pathway provides a major link between the cell surface and nucleus to control proliferation and differentiation. However, its in vivo role in skeletal development is unknown. A transgenic approach was used to establish a role for this pathway in bone. MAPK stimulation achieved by selective expression of constitutively active MAPK/ERK1 (MEK-SP) in osteoblasts accelerated in vitro differentiation of calvarial cells, as well as in vivo bone development, whereas dominant-negative MEK1 was inhibitory. The involvement of the RUNX2 transcription factor in this response was established in two ways: (a) RUNX2 phosphorylation and transcriptional activity were elevated in calvarial osteoblasts from TgMek-sp mice and reduced in cells from TgMek-dn mice, and (b) crossing TgMek-sp mice with Runx2+/ animals partially rescued the hypomorphic clavicles and undemineralized calvaria associated with Runx2 haploinsufficiency, whereas TgMek-dn; Runx2+/ mice had a more severe skeletal phenotype. This work establishes an important in vivo function for the ERKMAPK pathway in bone that involves stimulation of RUNX2 phosphorylation and transcriptional activity.
Abbreviations used in ths paper: ALP, alkaline phosphatase; BSP, bone sialoprotein; CCD, cleidocranial dysplasia; E, embryonic day; ERK, extracellular signalregulated kinase; GAP, GTPase-activating protein; MEK, MAPK/ERK; MEK-DN, dominant-negative MEK1; mOG, mouse osteocalcin gene; OCN, osteocalcin; OSE, osteoblast-specific element.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Matsushita, T., Chan, Y. Y., Kawanami, A., Balmes, G., Landreth, G. E., Murakami, S.
(2009). Extracellular Signal-Regulated Kinase 1 (ERK1) and ERK2 Play Essential Roles in Osteoblast Differentiation and in Supporting Osteoclastogenesis. Mol. Cell. Biol.
29: 5843-5857
[Abstract]
[Full Text]
-
Chang, S.-F., Chang, T.-K., Peng, H.-H., Yeh, Y.-T., Lee, D.-Y., Yeh, C.-R., Zhou, J., Cheng, C.-K., Chang, C. A., Chiu, J.-J.
(2009). BMP-4 Induction of Arrest and Differentiation of Osteoblast-Like Cells via p21CIP1 and p27KIP1 Regulation. Mol. Endocrinol.
23: 1827-1838
[Abstract]
[Full Text]
-
Carlson, J., Cui, W., Zhang, Q., Xu, X., Mercan, F., Bennett, A. M., Vignery, A.
(2009). Role of MKP-1 in Osteoclasts and Bone Homeostasis. Am. J. Pathol.
175: 1564-1573
[Abstract]
[Full Text]
-
Nakamura, T., Gulick, J., Pratt, R., Robbins, J.
(2009). Noonan syndrome is associated with enhanced pERK activity, the repression of which can prevent craniofacial malformations. Proc. Natl. Acad. Sci. USA
106: 15436-15441
[Abstract]
[Full Text]
-
Baniwal, S. K., Khalid, O., Sir, D., Buchanan, G., Coetzee, G. A., Frenkel, B.
(2009). Repression of Runx2 by Androgen Receptor (AR) in Osteoblasts and Prostate Cancer Cells: AR Binds Runx2 and Abrogates Its Recruitment to DNA. Mol. Endocrinol.
23: 1203-1214
[Abstract]
[Full Text]
-
Jonason, J.H., Xiao, G., Zhang, M., Xing, L., Chen, D.
(2009). Post-translational Regulation of Runx2 in Bone and Cartilage. JDR
88: 693-703
[Abstract]
[Full Text]
-
Li, Z., Hassan, M. Q., Jafferji, M., Aqeilan, R. I., Garzon, R., Croce, C. M., van Wijnen, A. J., Stein, J. L., Stein, G. S., Lian, J. B.
(2009). Biological Functions of miR-29b Contribute to Positive Regulation of Osteoblast Differentiation. J. Biol. Chem.
284: 15676-15684
[Abstract]
[Full Text]
-
Gu, X., Masters, K. S.
(2009). Role of the MAPK/ERK pathway in valvular interstitial cell calcification. Am. J. Physiol. Heart Circ. Physiol.
296: H1748-H1757
[Abstract]
[Full Text]
-
Miraoui, H., Oudina, K., Petite, H., Tanimoto, Y., Moriyama, K., Marie, P. J.
(2009). Fibroblast Growth Factor Receptor 2 Promotes Osteogenic Differentiation in Mesenchymal Cells via ERK1/2 and Protein Kinase C Signaling. J. Biol. Chem.
284: 4897-4904
[Abstract]
[Full Text]
-
Moenning, A., Jager, R., Egert, A., Kress, W., Wardelmann, E., Schorle, H.
(2009). Sustained Platelet-Derived Growth Factor Receptor {alpha} Signaling in Osteoblasts Results in Craniosynostosis by Overactivating the Phospholipase C-{gamma} Pathway. Mol. Cell. Biol.
29: 881-891
[Abstract]
[Full Text]
-
Panupinthu, N., Rogers, J. T., Zhao, L., Solano-Flores, L. P., Possmayer, F., Sims, S. M., Dixon, S. J.
(2008). P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis. JCB
181: 859-871
[Abstract]
[Full Text]
-
Li, Z., Hassan, M. Q., Volinia, S., van Wijnen, A. J., Stein, J. L., Croce, C. M., Lian, J. B., Stein, G. S.
(2008). A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc. Natl. Acad. Sci. USA
105: 13906-13911
[Abstract]
[Full Text]
-
Franceschi, R. T., Xiao, G.
(2007). Osteoblasts: Staying The Course. Meeting Report from the 29th Annual Meeting of the American Society for Bone and Mineral Research: September 16-19, 2007 in Honolulu, Hawaii, USA. IBMS BoneKEy
4: 327-332
[Full Text]
-
Ge, C., Xiao, G., Jiang, D., Franceschi, R. T.
(2007). Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. JEM
204: i6-i6
[Full Text]